Category Archives: Background reading

UK-CAB 62: HIV generic medication

Friday 21 April 2017 Venue Hotel Details Expenses  Programme 09.20-09.40 Arrival, tea and refreshments 09.40-10.00 Welcome and introductions, UK-CAB updates, Company pre-meeting (Garry to lead) 10.00-11.30 Company meeting: MSD 11.30-11.45 BREAK 11.45-12.30 CROI feedback – Simon Collins 12.30-14.00 LUNCH 14.00-15.15 Invited speakers: Switching to generic ARVs (commissioning) – Janette Harper, NHS England Switching to generic ARVs […]

Comments closed Edit

STIs and sexual function

STIs and Sexual Function 2009 paper

Comments closed Edit

Hepatitis C and HCV/HIV Coinfection – from NATAP (June 2002)

http://www.natap.org/2002/june/hep62402.htm natural course of history of disease progression in HCV and HCV/HIV coinfection Transmission of HCV Testing: genotype, viral load, genotype, stopping therapy at week 12 or 24 diagnostic tests: understanding the biopsy, ALT treatment for HCV in mono- and coinfected patients how does HAART affect the liver and what you can do about it […]

Comments closed Edit

The Body: ACRIA – Treatment Issues for Women

Report on Second Meeting Contents The Body: ACRIA – Treatment Issues for Women This document provides up-to-date information on each of the subjects below. Clicking on the link will take you to the webpage with the article. Language in these pages is very straight-forward and non-technical, so is a good general introduction and a good […]

Comments closed Edit

Preparation material for the fourth meeting

From NATAP: Co-infection with hepatitis among people with HIV is emerging as a growing problem. For people infected with HIV through needle exposure probably due to drug use, 40% or more may also have hepatitis C. The NATAP Hepatitis Section was started to raise awareness about this problem, and to provide basic education and more […]

Comments closed Edit

Women and HIV

Below are a series of weblinks to articles about women and HIV. Please print and read ONE for the next meeting. http://www.natap.org/women.htm AIDS is the leading cause of death among African American and Hispanic women ages 25-44 in the US. African American and Hispanic women accounted for 76% of new AIDS cases among women reported […]

Comments closed Edit

Reading Is Believing? A Guide to Clinical Trial Reports

Matt Sydes and Janet Darbyshire, MBChB Anyone who reads medical journals or other health-related publications, such as BETA, will have come across reports of clinical trials, an essential tool in evidence-based medicine. Clinical trials are a crucial step in medical research and development (R&D); they are used to test new drugs or treatments for a […]

Comments closed Edit

MRC HIV Trials

COTOX is an open randomised trial in individuals with HIV infection and with either a history of, or a current, mild to moderate skin and/or febrile reactions to co-trimoxazole. The trial compares a 10 day desensitisation with rechallenge to full doses when restarting co-trimoxazole as prophylaxis against Pneumocystis carinii pneunomia (PCP). It it planned to […]

Comments closed Edit

Thinking it Over: Is a Clinical Trial Right for Me?

From NIH: AIDS clinical trials: Talking it Over http://www.aidsvaccine.org/doc_2.htm Questions to ask the doctor Facts about the Study What is the purpose of the study? Who is running the study? Who is paying for the study? Who reviews the results? What treatment(s) may I receive Does the study use a placebo? Why do doctors believe […]

Comments closed Edit

A Guide for HIV/AIDS Community Advocates

collected by Julie Davids for Project TEACH, with help from Charles Nelson, Kiyoshi Kuromiya, and Jane Shull http://www.aidsvaccine.org/doc_5.htm Becoming an Advocate 1. It is important that you are doing this: Serving as a community representative is hard work. Other people have more experience than you, and may know more about the topic or the unspoken […]

Comments closed Edit